He L - Search Results

1

CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer.

Ying Y, Li J, Xie H, Yan H, Jin K, He L, Ma X, Wu J, Xu X, Fang J, Wang X, Zheng X, Liu B, Xie L. Ying Y, et al. Among authors: he l. Cell Prolif. 2020 Feb;53(2):e12751. doi: 10.1111/cpr.12751. Epub 2020 Jan 23. Cell Prolif. 2020. PMID: 31971654 Free PMC article.

2

METTL3/YTHDF2 m⁶ A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.

Xie H, Li J, Ying Y, Yan H, Jin K, Ma X, He L, Xu X, Liu B, Wang X, Zheng X, Xie L. Xie H, et al. Among authors: he l. J Cell Mol Med. 2020 Apr;24(7):4092-4104. doi: 10.1111/jcmm.15063. Epub 2020 Mar 3. J Cell Mol Med. 2020. PMID: 32126149 Free PMC article.

3

YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.

Li J, Xie H, Ying Y, Chen H, Yan H, He L, Xu M, Xu X, Liang Z, Liu B, Wang X, Zheng X, Xie L. Li J, et al. Among authors: he l. Mol Cancer. 2020 Oct 29;19(1):152. doi: 10.1186/s12943-020-01267-6. Mol Cancer. 2020. PMID: 33121495 Free PMC article.

4

miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis.

Wang W, Ying Y, Xie H, Li J, Ma X, He L, Xu M, Chen S, Shen H, Zheng X, Liu B, Wang X, Xie L. Wang W, et al. Among authors: he l. Cell Cycle. 2021 Jul;20(13):1242-1252. doi: 10.1080/15384101.2021.1929677. Epub 2021 Jul 1. Cell Cycle. 2021. PMID: 34196584 Free PMC article.

5

MicroRNA-501-3p inhibits the proliferation of kidney cancer cells by targeting WTAP.

He L, Chen S, Ying Y, Xie H, Li J, Ma X, Wang W, Shen H, Wang X, Zheng X, Xie L. He L, et al. Cancer Med. 2021 Oct;10(20):7222-7232. doi: 10.1002/cam4.4157. Epub 2021 Sep 30. Cancer Med. 2021. PMID: 34595849 Free PMC article.

6

Downregulation of N⁶-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N⁶-methyladenosine levels.

Li J, Meng S, Xu M, Wang S, He L, Xu X, Wang X, Xie L. Li J, et al. Among authors: he l. Oncotarget. 2017 Dec 18;9(3):3752-3764. doi: 10.18632/oncotarget.23365. eCollection 2018 Jan 9. Oncotarget. 2017. PMID: 29423080 Free PMC article.

7

The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.

He L, Li J, Wang X, Ying Y, Xie H, Yan H, Zheng X, Xie L. He L, et al. J Cell Mol Med. 2018 Oct;22(10):4630-4639. doi: 10.1111/jcmm.13804. Epub 2018 Jul 24. J Cell Mol Med. 2018. PMID: 30039919 Free PMC article. Review.

8

Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis.

Yan H, Ying Y, Xie H, Li J, Wang X, He L, Jin K, Tang J, Xu X, Zheng X. Yan H, et al. Among authors: he l. Cancer Manag Res. 2018 Sep 21;10:3781-3791. doi: 10.2147/CMAR.S175062. eCollection 2018. Cancer Manag Res. 2018. PMID: 30288109 Free PMC article. Review.

9

circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis.

Ma X, Ying Y, Sun J, Xie H, Li J, He L, Wang W, Chen S, Shen H, Yi J, Luo J, Wang X, Zheng X, Liu B, Xie L. Ma X, et al. Among authors: he l. Cell Death Discov. 2021 Nov 23;7(1):365. doi: 10.1038/s41420-021-00712-9. Cell Death Discov. 2021. PMID: 34811353 Free PMC article.

10

Clinicopathological impacts of c-Met overexpression in bladder cancer: evidence from 1,336 cases.

Xu X, Zhang G, He L, Zhu Y. Xu X, et al. Among authors: he l. Onco Targets Ther. 2019 Apr 10;12:2695-2702. doi: 10.2147/OTT.S197540. eCollection 2019. Onco Targets Ther. 2019. PMID: 31114223 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,339 results

Search Page

Filters